Transplantation, Autologous
"Transplantation, Autologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of an individual's own tissue from one site to another site.
| Descriptor ID |
D014182
|
| MeSH Number(s) |
E04.936.664
|
| Concept/Terms |
Transplantation, Autologous- Transplantation, Autologous
- Autotransplantation
- Autotransplantations
- Autografting
- Autograftings
- Autologous Transplantation
- Autologous Transplantations
- Transplantations, Autologous
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Autologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Autologous".
This graph shows the total number of publications written about "Transplantation, Autologous" by people in this website by year, and whether "Transplantation, Autologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 6 | 6 |
| 1999 | 2 | 7 | 9 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 7 | 7 |
| 2002 | 1 | 6 | 7 |
| 2003 | 0 | 11 | 11 |
| 2004 | 0 | 6 | 6 |
| 2005 | 2 | 3 | 5 |
| 2006 | 1 | 8 | 9 |
| 2007 | 0 | 5 | 5 |
| 2008 | 1 | 10 | 11 |
| 2009 | 2 | 7 | 9 |
| 2010 | 0 | 5 | 5 |
| 2011 | 1 | 7 | 8 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 11 | 11 |
| 2014 | 3 | 8 | 11 |
| 2015 | 0 | 9 | 9 |
| 2016 | 1 | 5 | 6 |
| 2017 | 3 | 13 | 16 |
| 2018 | 0 | 17 | 17 |
| 2019 | 2 | 13 | 15 |
| 2020 | 0 | 15 | 15 |
| 2021 | 2 | 27 | 29 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 5 | 5 |
| 2024 | 3 | 4 | 7 |
| 2025 | 0 | 4 | 4 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Autologous" by people in Profiles.
-
Tumor-targeted interferon-a gene therapy for glioblastoma: a phase 1 trial. Nat Med. 2026 Jun; 32(6):2216-2226.
-
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial. Lancet Haematol. 2026 Apr; 13(4):e241-e253.
-
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplant Cell Ther. 2026 Feb; 32(2):199.e1-199.e12.
-
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma. Blood Adv. 2025 Sep 23; 9(18):4687-4692.
-
Predictors of Diabetes Outcomes at 1 Year After Islet Autotransplantation: Data From a Multicenter Cohort Study. Diabetes Care. 2025 Sep 01; 48(9):1493-1501.
-
The role of maintenance therapy and its cessation in patients with multiple myeloma. Leuk Lymphoma. 2025 Dec; 66(13):2426-2436.
-
Islet Isolation Outcomes in Patients Undergoing Total Pancreatectomy With Islet Autotransplantation in the POST Consortium. Transplantation. 2025 01 01; 109(1):207-216.
-
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role? Cells. 2024 10 27; 13(21).
-
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood Cancer J. 2024 07 08; 14(1):108.
-
Editorial Commentary: Three-Dimensional-Printed Biphasic (Osteochondral) Scaffolds Delivering Autologous Chondrocytes Hold Clinical Promise. Arthroscopy. 2025 03; 41(3):700-702.